Diagnostic value of serum procalcitonin in determining the activity of inflammatory bowel disease

Turkish Journal of Gastroenterology

Volumn 20, Issue 1, 2009, Pages 9-12

  Nevin, O R C ^a   Özütemi̊z, Ömer ^a   Osmanoǧlu, Necla ^a   I̊lter, Tankut ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

C reactive protein; Crohn's disease; Procalcitonin; Ulcerative colitis

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; PROCALCITONIN;

ADULT; ARTICLE; CLINICAL ARTICLE; COLON; COMPARATIVE STUDY; CONTROLLED STUDY; CROHN DISEASE; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE MARKER; ENTERITIS; FEMALE; HORMONE BLOOD LEVEL; HOSPITAL PATIENT; HUMAN; LEUKOCYTE COUNT; MALE; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SEDIMENTATION RATE; SENSITIVITY AND SPECIFICITY; SMALL INTESTINE; ULCERATIVE COLITIS;

ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROTEIN PRECURSORS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 63449116830     PISSN: 13004948     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Torres MI, Rios A. Current view of the immunopathogene- sis in inflammatory bowel disease and its implications for therapy. World J Gastroenterol 2008; 14: 1972-80.
2. Papp M, Norman GL, Altorjay I, Lakatos PL. Utility of se- rological markers in inflammatory bowel diseases: gadget or magic? World J Gastroenterol 2007; 13: 2028-36.
3. Desai D, Faubion WA, Sandborn WJ. Biological activity markers in inflammatory bowel disease. Aliment Pharmacol Ther 2007; 25: 247-55.
4. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448-54.
5. Vermeire S, Van Assche G, Rutgeerts P. Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut 2006; 55: 426-31.
6. Le Moullec JM, Jullienne A, Chenais J, et al. The complete sequence of human preprocalcitonin. FEBS Lett 1984; 167: 93-7.
7. Simon L, Gauvin F, Amre DK, et al. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 2004; 39: 206-17.
8. Eberhard OK, Haubitz M, Brunkhorst FM, et al. Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythemato- sus/systemic antineutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infection. Arthritis Rheum 1997; 40: 1250-6.
9. Moosig F, Csernok E, Reinhold-Keller E, et al. Elevated procalcitonin levels in active Wegener's granulomatosis. J Rheumatol 1998; 25: 1531-3.
10. Podolsky K. Inflammatory bowel disease. N Engl J Med 1991; 325: 928-37.
11. Best WR, Becktel JM, Singleton JW, Kern FJ. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976; 70: 439-44.
12. Truelove SC, Witts LJ. Cortisone in the treatment of ulce- rative colitis. Final report of a therapeutic trial. Br Med J 1955; 2: 1041-8.
13. Linskens RK, van Bodegraven AA, Schoorl M, et al. Predictive value of inflammatory and coagulation parameters in the course of severe ulcerative colitis. Dig Dis Sci 2001; 46: 644-8.
14. Muller CA, Uhl W, Printzen G, et al. Role of procalcitonin and granulocyte colony stimulating factor in the early prediction of infected necrosis in severe acute pancreatitis. Gut 2000; 46: 233-8.
15. Ammori BJ, Becker KL, Kite P, et al. Calcitonin precursors: early markers of gut barrier dysfunction in patients with acute pancreatitis. Pancreas 2003; 27: 239-43.
16. Sarbinowski R, Arvidsson S, Tylman M, et al. Plasma concentration of procalcitonin and systemic inflammatory response syndrome after colorectal surgery. Acta Anaesthesi-ol Scand 2005; 49: 191-6.
17. Fagan EA, Dyck RF, Maton PN, et al. Serum levels of C-re- active protein in Crohn's disease and ulcerative colitis. Eur J Clin Invest 1982; 12: 351-9.
18. Herrlinger KR, Dittmann R, Weitz G, et al. Serum procal- citonin differentiates inflammatory bowel disease and self- limited colitis. Inflamm Bowel Dis 2004; 10: 229-33.
19. White A, Fletcher TC. The influence of hormones and inflammatory agents on C-reactive protein, cortisol and alani- ne aminotransferase in the plaice (Pleuronectes platessa L.). Comp Biochem Physiol C 1985; 80: 99-104.